Effect of metallothionein core promoter region polymorphism on cadmium, zinc and copper levels in autopsy kidney tissues from a Turkish population

Toxicology and Applied Pharmacology

Volumn 245, Issue 2, 2010, Pages 252-255

  Kayaalti, Zeliha ^a   Mergen, Görkem ^a   Söylemezoǧlu, Tülin ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Autopsy; Kidney; Metallothionein 2A; Metals; PCR RFLP; Polymorphism

Indexed keywords

CADMIUM; COPPER; METALLOTHIONEIN II; ZINC;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; AUTOPSY; CONTROLLED STUDY; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; KIDNEY CORTEX; KIDNEY PARENCHYMA; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOPSY; CADMIUM; COPPER; FEMALE; GENOTYPE; HUMANS; KIDNEY; MALE; METALLOTHIONEIN; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TURKEY; YOUNG ADULT; ZINC;

EID: 77952890340     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.03.007     Document Type: Article

References (34)

1. Aalbers T.G., Houtman J.P.W., Makkink B. Trace-element concentrations in human autopsy tissue. Clin. Chem. 1987, 33:2057-2064.
2. Amaral A.F., Cymbron T., Gärtner F., Lima M., Rodrigues A.S. Trace metals and over-expression of metallothioneins in bladder tumoral lesions: a case-control study. BMC Vet. Res. 2009, 5:24.
3. Bocio A., Nadal M., Garcia F., Domingo J.L. Monitoring metals in the population living in the vicinity of a hazardous waste incinerator: concentrations in autopsy tissues. Biol. Trace Elem. Res. 2005, 106:41-50.
4. Bremner I. Manifestations of copper excess. Am. J. Clin. Nutr. 1998, 67:1069-1073.
5. Cherian M.G., Kang Y.J. Metallothionein and liver cell regeneration. Exp. Biol. Med. 2006, 231:138-144.
6. Chung J.H., Kim C.Y., Sakong J., Lee J.J., Jeon M.J., Lee S.K., Kwak J.S., Park S.H. Concentration of lead, cadmium, and mercury in scalp hair, cerebellum, cerebrum, heart, kidney, liver, lung and spleen from autopsy subjects-relationship between scalp hair and internal organs Korean. J. Occup. Environ. Med. 1998, 10:571-586.
7. Ebert M.P., Günther T., Hoffmann J., Yu J., Miehlke S., Schulz H.U., Roessner A., Korc M., Malfertheiner P. Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer. Cancer Res. 2000, 60:1995-2001.
8. Garcia F., Ortega A., Domingo J.L., Corbella J. Accumulation of metals in autopsy tissues of subjects living in Tarragona County, Spain. J. Environ. Sci. Health 2001, A36:1767-1786.
9. Giacconi R., Cipriano C., Muti E., Costarelli L., Maurizio C., Saba V., Gasparini N., Malavolta M., Mocchegiani E. Novel-209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc. Biogerontology 2005, 6:407-413.
10. Giacconi R., Muti E., Malavolta M., Cipriano C., Costarelli L., Bernardini G., Gasparini N., Mariani E., Saba V., Boccoli G., Mocchegiani E. The +838 C/G MT2A polymorphism, metals, and the inflammatory/immune response in carotid artery stenosis in elderly people. Mol. Med. 2007, 13:388-395.
11. Goering P.L., Klaassen C.D. Tolerance to cadmium-induced toxicity depends on presynthesized metallothionein in liver. J. Toxicol. Environ. Health 1984, 14:803-812.
12. Hayashi Y., Hashizume T., Wakida K., Satoh M., Uchida Y., Watabe K., Matsuyama Z., Kimura A., Inuzuka T., Hozumi I. Association between metallothionein genes polymorphisms and sporadic amyotrophic lateral sclerosis in a Japanese population. Amyotroph. Lateral Scler. 2006, 7:22-26.
13. Hellstrom L., Elinder C.G., Dahlberg B., Lundberg M., Jarup L., Persson B., Axelson O. Cadmium exposure and end-stage renal disease. Am. J. Kidney Dis. 2001, 38:1001-1008.
14. Jacob C., Maret W., Vallee B.L. Control of zinc transfer between thionein, metallothionein, and zinc proteins. Proc. Natl. Acad. Sci. 1998, 95:3489-3494.
15. Jin T., Lu J., Nordberg M. Toxicokinetics and biochemistry of cadmium with special emphasis on the role of metallothionein. Neurotoxicology 1998, 19:529-535.
16. Kägi J.H. Overview of metallothionein. Methods Enzymol. 1991, 205:613-626.
17. Kayaalti Z., Söylemezoǧlu T. The polymorphism of core promoter region on metallothionein 2A-metal binding protein in Turkish population. Mol. Biol. Rep. 2010, 37:185-190.
18. Kita K., Miura N., Yoshida M., Yamazaki K., Ohkubo T., Imai Y., Naganuma A. Potential effect on cellular response to cadmium of a single-nucleotide A->G polymorphism in the promoter of the human gene for metallothionein IIA. Hum. Genet. 2006, 120:553-560.
19. Klaassen C.D., Liu J., Choudhuri S. Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu. Rev. Pharmacol. Toxicol. 1999, 39:267-294.
20. Klaassen C.D., Liu J., Diwan B.A. Metallothionein protection of cadmium toxicity. Toxicol. Appl. Pharmacol. 2009, 238:215-220.
21. Kondo Y., Woo E.S., Michalska A.E., Choo K.H., Lazo J.S. Metallothionein null cells have increased sensitivity to anticancer drugs. Cancer Res. 1995, 55:2021-2023.
22. Liu J., Kershaw W.C., Klaassen C.D. The protective effect of metallothionein on the toxicity of various metals in rat primary hepatocyte culture. Toxicol. Appl. Pharmacol. 1991, 107:27-34.
23. Liu Y., Liu J., Iszard M.B., Andrews G.K., Palmiter R.D., Klaassen C.D. Transgenic mice that overexpress metallothionein-I are protected from cadmium lethality and hepatotoxicity. Toxicol. Appl. Pharmacol. 1995, 135:222-228.
24. Liu Y., Liu J., Habeebu S.M., Waalkes M.P., Klaassen C.D. Metallothionein-I/II null mice are sensitive to chronic oral cadmium-induced nephrotoxicity. Toxicol. Sci. 2000, 57:167-176.
25. Lu J., Jin T., Nordberg G., Nordberg M. Metallothionein gene expression in peripheral lymphocytes from cadmium-exposed workers. Cell Stress Chaperones 2001, 6:97-104.
26. Maret W., Vallee B.L. Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc. Natl. Acad. Sci. 1998, 95:3478-3482.
27. Messner B., Knoflach M., Seubert A., Ritsch A., Pfaller K., Henderson B., Shen Y.H., Zeller I., Willeit J., Laufer G., Wick G., Kiechl S., Bernhard D. Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1392-1398.
28. Miura N. Individual susceptibility to cadmium toxicity and metallothionein gene polymorphisms: with references to current status of occupational cadmium exposure. Ind. Health 2009, 47:487-494.
29. Nordberg M. Metallothioneins: historical review and state of knowledge. Talanta 1998, 46:243-254.
30. Samson S.L., Gedamu L. Molecular analyses of metallothionein gene regulation. Prog. Nucleic Acid Res. Mol. Biol. 1998, 59:257-288.
31. Schwartz G.G., Reis I.M. Is cadmium a cause of human pancreatic cancer?. Cancer Epidemiol Biomarkers Prev. 2000, 9:139-145.
32. Trzcinka-Ochocka M., Jakubowski M., Razniewska G., Halatek T., Gazewski A. The effects of environmental cadmium exposure on kidney function: the possible influence of age. Environ. Res. 2004, 95:143-150.
33. Vasak M. Advances in metallothionein structure and functions. J. Trace Elem. Med. Biol. 2005, 19:13-17.
34. Yoshida M., Ohta H., Yamauchi Y., Seki Y., Sagi M., Yamazaki K., Sumi Y. Age-dependent changes in metallothionein levels in liver and kidney of the Japanese. Biol. Trace Elem. Res. 1998, 63:167-175.